Skip to main content
. 2011 May 31;5(5):e1171. doi: 10.1371/journal.pntd.0001171

Figure 3. Immunohistochemical analysis of Foxp3 in tissue lesions of PKDL patients.

Figure 3

Distribution of Foxp3 in dermal lesion tissue sections at pre treatment, post treatment stages and normal skin of healthy individuals. Panel A (10×), Panel B (40×) magnification.